Basilea Pharmaceutica AG Market Cap

Basilea Pharmaceutica AG has a market cap or net worth of 649.00 million as of March 9, 2026. Its market cap has increased by 20.91% in one year.

Market Cap

649.00M

Enterprise Value

578.42M

Revenue

232.38M

Ranking

n/a

PE Ratio

16.80

Stock Price

52.80

Market Cap Chart

Since March 25, 2004, Basilea Pharmaceutica AG's market cap has increased from 533.29M to 649.00M, an increase of 21.70%. That is a compound annual growth rate of 0.90%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	639.16M	-4.91%
Dec 30, 2025	672.13M	34.10%
Dec 30, 2024	501.21M	18.52%
Dec 29, 2023	422.90M	-22.52%
Dec 30, 2022	545.84M	12.62%
Dec 30, 2021	484.67M	-15.59%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Idorsia	887.82M
Newron Pharmaceuticals	366.19M
Santhera Pharmaceuticals Holding AG	213.08M
BioVersys AG	149.71M
Molecular Partners AG	145.86M
Xlife Sciences AG	127.46M
EvoNext Holdings	6.98M
Addex Therapeutics	5.83M

Market Cap Rankings